Avantor Inc. (AVTR) PT Lowered to $13 at UBS

UBS analyst Dan Leonard lowered the price target on Avantor Inc. (NYSE: AVTR) to $13.00 (from $14.00) while maintaining a Neutral rating.

The analyst commented, "Our Neutral rating on Avantor (AVTR) reflects our view that outsized exposure to market headwinds and channel share risks could depress sales growth below industry peers' (by 2%+ over a cycle), while broader considerations (higher interest rates, higher target valuations, a high relative debt burden) could complicate efforts to structurally accelerate sales growth. Avantor's below market bioprocessing results and guidance reductions in organic sales and adj. EBITDA support our thesis."

You May Also Be Interested In

• Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
• Dover Corp. (DOV) PT Raised to $230 at Morgan Stanley
• MaxLinear (MXL) PT Raised to $105 at Stifel